API/Priceline pay shortfall review nears completion

Almost ten months since the investigation was announced A review of payroll practices at Australian Pharmaceutical Industries (API) after “historical payment errors” were flagged is nearing completion, according to the company.  The review, which was announced by Wesfarmers managing director Rob Scott in conjunction with the API parent company’s FY22 results in August 2022, came

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous TGA issues $40k in fines for complementaries ads
Next Call for abstracts